{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:53:45Z","timestamp":1790351625370,"version":"4.1.0"},"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["355837-2013"],"award-info":[{"award-number":["355837-2013"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003400","name":"Ministry of Research and Innovation","doi-asserted-by":"publisher","award":["ER13-09-040"],"award-info":[{"award-number":["ER13-09-040"]}],"id":[{"id":"10.13039\/501100003400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180582","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T17:39:27Z","timestamp":1499708367000},"page":"e0180582","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3592-6770","authenticated-orcid":true,"given":"Hana M.","family":"Dobrovolny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A. A.","family":"Beauchemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/v7092850","article-title":"Clinical Implications of Antiviral Resistance in Influenza","volume":"7","author":"TCM Li","year":"2015","journal-title":"Viruses-Basel"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Y Abed","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(06)67970-1","article-title":"Antivirals for influenza in healthy adults: systematic review","volume":"367","author":"T Jefferson","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005\u20132006 influenza season in the United States","volume":"295","author":"RA Bright","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/344237","article-title":"Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene","volume":"186","author":"Y Abed","year":"2002","journal-title":"J Infect Dis"},{"issue":"9206","key":"ref6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"LV Gubareva","year":"2000","journal-title":"Lancet"},{"issue":"46","key":"ref7","first-page":"355","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: a Cochrane review","volume":"14","author":"T Jefferson","year":"2010","journal-title":"Health Technology Assessment"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/jama.1996.03530280047035","article-title":"Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza","volume":"275","author":"FG Hayden","year":"1996","journal-title":"JAMA"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"FG Hayden","year":"1999","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jtbi.2008.05.031","article-title":"Modeling amantadine treatment of influenza A virus in vitro","volume":"254","author":"CAA Beauchemin","year":"2008","journal-title":"J Theor Biol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/JVI.62.5.1508-1512.1988","article-title":"Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection","volume":"62","author":"RB Belshe","year":"1988","journal-title":"J Virol"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.01385-09","article-title":"In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure","volume":"54","author":"AN Brown","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1506.081357","article-title":"Oseltamivir- and amantadine-resistant influenza viruses A (H1N1)","volume":"15","author":"PKC Cheng","year":"2009","journal-title":"Emerg Infect Diseases"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"M Baz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref15","first-page":"1034","article-title":"Local and Systemic Cytokine Responses during Experimental Human Influenza A Virus Infection","volume":"301","author":"NJ Dharan","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/JCM.01532-09","article-title":"Genetic Makeup of Amantadine-Resistant and Oseltamivir-Resistant Human Influenza A\/H1N1 Viruses","volume":"48","author":"H Zaraket","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"7258","key":"ref17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","volume":"460","author":"Y Itoh","year":"2009","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318537","article-title":"Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir","volume":"183","author":"LV Gubareva","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JVI.70.3.1818-1827.1996","article-title":"Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en","volume":"70","author":"LV Gubareva","year":"1996","journal-title":"J Virol"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","article-title":"Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir","volume":"46","author":"MZ Wang","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"ref21","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1128\/JVI.07244-11","article-title":"The H275Y Neuraminidase Mutation of the Pandemic A\/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets","volume":"86","author":"LT Pinilla","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"e14767","DOI":"10.1371\/journal.pone.0014767","article-title":"Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A\/H1N1 Influenza Strain Using a Mathematical Model","volume":"6","author":"BP Holder","year":"2011","journal-title":"PLOS One"},{"issue":"19","key":"ref23","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00985-12","article-title":"Comparable Fitness and Transmissibility between Oseltamivir-Resistant Pandemic 2009 and Seasonal H1N1 Influenza Viruses with the H275Y Neuraminidase Mutation","volume":"86","author":"DD Wong","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jac\/dkq486","article-title":"Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness","volume":"66","author":"DW Brookes","year":"2011","journal-title":"J Antimicrob Ther"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets","volume":"190","author":"ML Herlocher","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo","volume":"55","author":"JAL Ives","year":"2002","journal-title":"Antiviral Res"},{"issue":"16","key":"ref27","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/JVI.00689-10","article-title":"Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model","volume":"84","author":"E Govorkova","year":"2010","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1098\/rspb.2007.0422","article-title":"Emergence of drug resistance: implications for antiviral control of pandemic influenza","volume":"274","author":"ME Alexander","year":"2007","journal-title":"Proc R Soc B"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1098\/rsif.2007.1126","article-title":"The effect of population structure on the emergence of drug resistance during influenza pandemics","volume":"4","author":"F Debarre","year":"2007","journal-title":"J R Soc Interface"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/jac\/dkg136","article-title":"A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals","volume":"51","author":"NM Ferguson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1098\/rspb.2008.0016","article-title":"Management of drug resistance in the population: influenza as a case study","volume":"275","author":"SM Moghadas","year":"2008","journal-title":"Proc R Soc B"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jtbi.2007.05.009","article-title":"Stochastic model of an influenza epidemic with drug resistance","volume":"248","author":"Y Xu","year":"2007","journal-title":"J Theor Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtbi.2008.09.021","article-title":"Antiviral resistance and the control of pandemic influenza: The roles of stochasticity, evolution and model details","volume":"256","author":"A Handel","year":"2009","journal-title":"J Theor Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1098\/rsif.2011.0427","article-title":"The global spread of drug-resistant influenza","volume":"9","author":"DL Chao","year":"2011","journal-title":"J R Soc Interface"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mbs.2013.03.003","article-title":"A model for the emergence of drug resistance in the presence of asymptomatic infections","volume":"243","author":"M Robinson","year":"2013","journal-title":"Math Biosci"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"e1002912","DOI":"10.1371\/journal.pcbi.1002912","article-title":"The Timing and Targeting of Treatment in Influenza Pandemics Influences the Emergence of Resistance in Structured Populations","volume":"9","author":"BM Althouse","year":"2013","journal-title":"PLoS Comput Biol"},{"issue":"1\u20132","key":"ref37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00285-015-0887-y","article-title":"Can treatment increase the epidemic size?","volume":"72","author":"Y Xiao","year":"2016","journal-title":"J Math Biol"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1371\/journal.pcbi.0030240","article-title":"Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread","volume":"3","author":"A Handel","year":"2007","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"e0126115","DOI":"10.1371\/journal.pone.0126115","article-title":"Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility","volume":"10","author":"EG Paradis","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"e1004065","DOI":"10.1371\/journal.ppat.1004065","article-title":"Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1) pdm09 Influenza Viruses","volume":"10","author":"J Butler","year":"2014","journal-title":"PLOS Path"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jtbi.2015.07.003","article-title":"Quantifying relative within-host replication fitness in influenza virus competition experiments","volume":"382","author":"SM Petrie","year":"2015","journal-title":"J Theor Biol"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"e1003568","DOI":"10.1371\/journal.pcbi.1003568","article-title":"Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study","volume":"10","author":"L Canini","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/infdis\/jis265","article-title":"Combination antiviral therapy for influenza: Predictions from modeling of human infections","volume":"205","author":"AS Perelson","year":"2012","journal-title":"J Infect Dis"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"e68235","DOI":"10.1371\/journal.pone.0068235","article-title":"Model-Based Simulation and Prediction of an Antiviral Strategy against Influenza A Infection","volume":"8","author":"KY Hur","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1073\/pnas.90.9.4171","article-title":"Rates of spontaneous mutation among RNA viruses","volume":"90","author":"JW Drake","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref46","first-page":"43","article-title":"Antiviral Drug Resistance","author":"AJ Hay","year":"1996"},{"key":"ref47","first-page":"59","article-title":"Antiviral Drug Resistance","author":"FG Hayden","year":"1996"},{"issue":"15","key":"ref48","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.01623-05","article-title":"Kinetics of influenza A virus infection in humans","volume":"80","author":"P Baccam","year":"2006","journal-title":"J Virol"},{"key":"ref49","article-title":"The Lung: Scientific Foundations","author":"RG Crystal","year":"1991"},{"issue":"9","key":"ref50","first-page":"3484","article-title":"Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008","volume":"52","author":"TG Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/135965350601100804","article-title":"Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic background","volume":"11","author":"Y Abed","year":"2006","journal-title":"Antivir Ther"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.49.10.4075-4084.2005","article-title":"Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility","volume":"49","author":"HL Yen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JVI.80.5.2380-2389.2006","article-title":"Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay","volume":"80","author":"HL Wu","year":"2006","journal-title":"J Virol"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coviro.2012.07.007","article-title":"Viral fitness: definitions, measurement, and current insights","volume":"2","author":"AR Wargo","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1083\/jcb.98.1.308","article-title":"Intracellular Transport of Influenza Virus Hemagglutinin to the Apical Surface of Madin-Darby Canine Kidney Cells","volume":"98","author":"E Rodriguez-Boulan","year":"1984","journal-title":"J Cell Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1083\/jcb.103.4.1179","article-title":"Assembly of Influenza Hemagglutinin Trimers and Its Role in Intracellular Transport","volume":"103","author":"C Copeland","year":"1986","journal-title":"J Cell Biol"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/JVI.68.3.1812-1818.1994","article-title":"Analysis of the signals for polarized transport of influenza virus (A\/WSN\/33) neuraminidase and human transferrin receptor, type II transmembrane proteins","volume":"68","author":"A Kundu","year":"1994","journal-title":"J Virol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(89)81161-5","article-title":"Influenza neuraminidase is delivered directly to the apical surface of MDCK cell monolayers","volume":"244","author":"PU Daniels","year":"1989","journal-title":"FEBS Lett"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1128\/JVI.66.9.5542-5552.1992","article-title":"Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells","volume":"66","author":"P Hughey","year":"1992","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0042-6822(85)90423-4","article-title":"Transcription and Replication of Eight RNA Segments of Influenza Virus","volume":"142","author":"M Enami","year":"1985","journal-title":"Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jviromet.2010.04.017","article-title":"Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics","volume":"168","author":"D Vester","year":"2010","journal-title":"J Virol Methods"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.7883\/yoken.JJID.2004.236","article-title":"Defense mechanisms against influenza virus infection in the respiratory tract mucosa","volume":"57","author":"S Tamura","year":"2004","journal-title":"Jpn J Infect Dis"},{"issue":"2","key":"ref63","doi-asserted-by":"crossref","first-page":"e57088","DOI":"10.1371\/journal.pone.0057088","article-title":"Assessing mathematical models of influenza infections using features of the immune response","volume":"8","author":"HM Dobrovolny","year":"2013","journal-title":"PLoS One"},{"key":"ref64","article-title":"Elementary Numerical Analysis","author":"K Atkinson","year":"1985"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"e13811","DOI":"10.1371\/journal.pone.0013811","article-title":"Exploring cell tropism as a possible contributor to influenza infection severity","volume":"5","author":"HM Dobrovolny","year":"2010","journal-title":"PLoS ONE"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.coviro.2011.08.006","article-title":"Fitness of neuraminidase inhibitor-resistant influenza A viruses","volume":"1","author":"T Baranovich","year":"2011","journal-title":"Curr Opin Virol"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JCM.01732-10","article-title":"The I222V Neuraminidase Mutation Has a Compensatory Role in Replication of an Oseltamivir-Resistant Influenza Virus A\/H3N2 E119V Mutant","volume":"49","author":"P Simon","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.meegid.2015.04.009","article-title":"Intra-host viral variability in children clinically infected with H1N1 (2009) pandemic influenza","volume":"33","author":"V Bourret","year":"2015","journal-title":"Infect Genet Evol"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2004.05.009","article-title":"Antiviral treatment and prophylaxis of influenza in primary care: German recommendations","volume":"31","author":"P Wutzler","year":"2004","journal-title":"J Clin Virol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(06)70684-3","article-title":"WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus","volume":"7","author":"HJ Schunemann","year":"2007","journal-title":"Lancet Infectious Diseases"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fcimb.2016.00060","article-title":"Oseltamivir PK\/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection","volume":"6","author":"A Boianelli","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2012.09.001","article-title":"Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors","volume":"92","author":"X Zhao","year":"2012","journal-title":"Antiviral Res"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"e1305","DOI":"10.1371\/journal.pone.0001305","article-title":"A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination","volume":"2","author":"D Morrison","year":"2007","journal-title":"PLOS One"},{"issue":"5","key":"ref74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3851\/IMP1794","article-title":"Reduced airborne transmission of oseltamivir-resistant pandemic A\/H1N1 virus in ferrets","volume":"16","author":"ME Hamelin","year":"2011","journal-title":"Antivir Ther"},{"issue":"21","key":"ref75","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.01424-10","article-title":"Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models","volume":"84","author":"C Seibert","year":"2010","journal-title":"J Virol"},{"issue":"18","key":"ref76","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1128\/JVI.00373-10","article-title":"Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model","volume":"84","author":"AC Hurt","year":"2010","journal-title":"J Virol"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.05994-11","article-title":"Impact of Mutations at Residue I223 of the Neuraminidase Protein on the Resistance Profile, Replication Level, and Virulence of the 2009 Pandemic Influenza Virus","volume":"56","author":"A Pizzorno","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref78","first-page":"1652","article-title":"Yacine Abed and Andres Pizzorno and Xavier Bouhy and Chantal Rheaume and Guy Boivin","volume":"88","author":"Y Abed","year":"2014","journal-title":"Journal of Virology"},{"key":"ref79","first-page":"153","article-title":"Influenza A: Understanding the Viral Life Cycle","volume":"82","author":"T Samji","year":"2009","journal-title":"Yale J Biol Med"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2009.05.010","article-title":"Influenza virus morphogenesis and budding","volume":"143","author":"DP Nayak","year":"2009","journal-title":"Virus Research"},{"issue":"11","key":"ref81","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/j.1558-5646.2012.01687.x","article-title":"Influence of Viral Replication Mechnisms on Within-Host Evolutionary Dynamics","volume":"66","author":"C Loverdo","year":"2012","journal-title":"Evolution"},{"issue":"6","key":"ref82","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/evo.12048","article-title":"Intergenerational Phenotypic Mixing in Viral Evolution","volume":"67","author":"C Loverdo","year":"2013","journal-title":"Evolution"},{"issue":"6","key":"ref83","doi-asserted-by":"crossref","first-page":"e1002588","DOI":"10.1371\/journal.pcbi.1002588","article-title":"Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses","volume":"8","author":"KA Pawelek","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"40210","DOI":"10.1038\/srep40210","article-title":"The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients","volume":"7","author":"J Palmer","year":"2017","journal-title":"Sci Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:21:55Z","timestamp":1719310915000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180582"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":84,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180582","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}